The vaccine maker, which has partnered with OpenAI since 2023, is rethinking how it does workforce planning thanks to the ...

Back in 2024, on May 14, Mad Money’s Jim Cramer was asked about Moderna, Inc. (NASDAQ:MRNA), explaining that some family ...

A combination shot for flu and Covid-19 using messenger RNA generated antibodies in a study, but US government regulators ...

The stock might be down substantially over the past three years, but it isn't out of the picture yet. Teladoc Health is a ...

The agency narrowed who can get the shot and added new study requirements that could cost the company tens of millions.

Kennedy’s FDA approved the use of the Novavax Covid-19 vaccine, but with strict conditions. It will only be made available to older people and those over the age of 12 with at least one medical ...

More than 3,000 GPTs are reportedly in use at Moderna, which has partnered with OpenAI. Here's how they're using the technology.

After a six-week long delay, The Food and Drug Administration (FDA) has finally approved a more traditional protein-based ...

Moderna will merge its technology and HR teams departments, thanks to their increasing reliance on AI and ongoing OpenAI ...

Novavax originally showed its vaccine was safe and effective in a 30,000-person clinical trial. The FDA had been on track to ...

Learn more about whether Kymera Therapeutics, Inc. or Moderna, Inc. is a better investment based on AAII's A+ Investor grades ...

The vaccine will only be available to those at high risk from Covid—excluding those who may need it to protect a relative or ...